Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Insight Molecular Diagnostics (IMDX) Asset Utilization Ratio (2020 - 2026)

Insight Molecular Diagnostics' Asset Utilization Ratio history spans 6 years, with the latest figure at 0.12 for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 225.71% to 0.12 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.12, a 225.71% increase, with the full-year FY2025 number at 0.13, up 289.69% from a year prior.
  • Asset Utilization Ratio hit 0.12 in Q4 2025 for Insight Molecular Diagnostics, up from 0.09 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for IMDX hit a ceiling of 0.12 in Q4 2025 and a floor of 0.01 in Q4 2022.
  • Historically, Asset Utilization Ratio has averaged 0.04 across 5 years, with a median of 0.03 in 2021.
  • Biggest five-year swings in Asset Utilization Ratio: tumbled 84.21% in 2022 and later surged 852.71% in 2025.
  • Tracing IMDX's Asset Utilization Ratio over 5 years: stood at 0.05 in 2021, then tumbled by 84.21% to 0.01 in 2022, then skyrocketed by 158.11% to 0.02 in 2023, then surged by 85.98% to 0.04 in 2024, then soared by 225.71% to 0.12 in 2025.
  • Business Quant data shows Asset Utilization Ratio for IMDX at 0.12 in Q4 2025, 0.09 in Q3 2025, and 0.08 in Q2 2025.